Researchers at DGIST discovered how somatostatin, a brain neurotransmitter, regulates immune cells to reduce Alzheimer's disease severity. The breakthrough enables repurposing existing medications for dementia treatment by shifting immune cells into
← News
Science Breakthroughs Science Breakthroughs Knowledge
Somatostatin in brain regulates immune cells to mitigate dementia, opening path for treatment with existing drugs
DGIST Korea Discovery location
Somatostatin Key molecule
Brain Immune Cells Target mechanism
Drug Repurposing Clinical approach
Alzheimer'S Disease Disease focus
Repurposing Existing Drugs approach
Neurotransmitter Regulation mechanism
Immune Cell Reprogramming innovation